NCT07498790Completed
Equal-Volume Pilates Frequency in Women With Overweight and Obesity
Effects of Equal-Volume Pilates Training Delivered at Different Weekly Frequencies on Functional Performance, Musculoskeletal Symptoms, and Quality of Life in Women With Overweight and Obesity
Source: ClinicalTrials.gov · Last updated 27 Mar 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn whether doing Pilates two days per week or three days per week leads to different health outcomes in women with overweight and obesity, when the total number of exercise sessions is the same. The study focuses on how these two Pilates schedules affect daily movement, balance, body measurements, and quality of life. The main questions it aims to answer are: When participants complete a total of thirty-six Pilates sessions, are there differences in functional performance between a program done three days per week for twelve weeks and a program done two days per week for eighteen weeks? Which program improves balance more? Which program improves obesity-related quality of life more? Are there differences between the two programs in waist and hip measurements, physical activity level, and musculoskeletal complaints? Researchers will compare two supervised Pilates programs: Pilates done three times per week for twelve weeks (thirty-six sessions total) Pilates done two times per week for eighteen weeks (thirty-six sessions total) Participants will: Be randomly assigned by computer to one of the two Pilates programs Take part in thirty-six supervised, mat-based Pilates sessions Have exercise intensity checked during sessions using the Borg Rating of Perceived Exertion scale Complete tests and measurements at the start and end of the study, such as walking and balance tests, body measurements, and questionnaires Be encouraged to walk at least two days per week on days without Pilates and record this activity in an exercise diary.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 51 (actual)
- First submitted
- 18 Feb 2026
- Start date
- 11 Sept 2023
- Primary completion date
- 15 Dec 2023
- Lead sponsor
- Pamukkale University
- Diseases
- Obesity
- NCT number
- NCT07498790
What you commit to
- Study type: Interventional
- Participants enrolled: 51
- From 11 Sept 2023 to the primary completion date, 15 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Musculoskeletal surgery within the previous six months.
- Use of medications known to affect bone metabolism.
- Presence of metallic implants or electronic devices (e.g., pacemakers).
Other illness
- Severe cardiopulmonary disease (e.g., recent myocardial infarction or unstable angina).
- Musculoskeletal, neuromuscular, or cognitive conditions interfering with safe participation.
Other
- Pregnancy.
Who the study is looking for
- Female participants aged 18-65 years.
- Body mass index (BMI) ≥27 kg/m².
- Waist circumference \>88 cm.
- Ability to ambulate independently.
- Sufficient cognitive ability to understand instructions and cooperate with assessments.
- Willingness to participate and provide written informed consent.
Age in the registry: 18 years to 65 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pamukkale University, Faculty of Physiotherapy and Rehabilitation Coordinator of this site? Confirm its status | Denizli | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.